Skip to content
MedsAcross

Brand family

Palsonify

Paltusotine · Crinetics Pharmaceuticals
United States
Presentations
2
Markets
1

Palsonify is a brand of Paltusotine marketed by Crinetics Pharmaceuticals, with 2 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.

Active ingredient (INN)
Paltusotine
Brand owner
Crinetics Pharmaceuticals
Registered in
United States
Strengths and forms
20 mg tablet, 30 mg tablet

All presentations

MedicineManufacturerRegisterAvailability
Palsonify 20 mg tabletOralCrinetics PharmaceuticalsUS FDAAvailable on request
Palsonify 30 mg tabletOralCrinetics PharmaceuticalsUS FDAAvailable on request

Brand names and trademarks belong to their owners and are used only to identify products.

Request Palsonify

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.